DRUG · Unmapped registry intervention
Mifepristone 600 mg daily
Find medicine records ·
Find other trials using this name
Clinical trial
Efficacy of Mifepristone in Males With Type 2 Diabetes Mellitus
NCT03052400
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Unmapped registry intervention
Placebo
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedEfficacy of Mifepristone in Males With Type 2 Diabetes Mellitus
Design: INTERVENTIONAL · Status: TERMINATED · Phase: PHASE2
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Insulin Resistanceunresolved
Interventions
PlaceboDRUG
Sponsors & collaborators
Charles Drew University of Medicine and Sciencelead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03052400 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.